Skip to main content

Healthcare Realty Trust Inc

corporate_fare Company Profile

Healthcare Realty Trust Inc

HR·NYSE·Real Estate & Construction·CIK 0001360604

Healthcare Realty Trust Incorporated is a real estate investment trust (REIT) that owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties primarily associated with outpatient healthcare services across the United States. As of December 31, 2025, the Company had gross investments of approximately $10.3 billion in 502 consolidated real estate properties, which include construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development, and corporate property. This excludes assets held for sale. The Company also held a weighted average ownership interest of approximately 30% in 61 real estate properties within unconsolidated joint ventures as of December 31, 2025, excluding held for sale assets. Healthcare Realty provided leasing and property management services to approximately 93% of its portfolio nationwide as of the same date. The Company's owned properties by facility type as of December 31, 2025, include: - Medical office/outpatient properties: $9,306,615 (dollars in thousands) across 26,690 (square feet in thousands) in 481 properties, with an occupancy of 89.6%. - Inpatient properties: $406,399 (dollars in thousands) across 869 (square feet in thousands) in 14 properties, with an occupancy of 100.0%. - Office properties: $272,967 (dollars in thousands) across 1,096 (square feet in thousands) in 4 properties, with an occupancy of 99.5%. Total real estate investments amounted to $10,292,596 (dollars in thousands) across 28,951 (square feet in thousands) in 502 properties, with an overall occupancy of 90.4%.

Healthcare Realty Trust Inc (NYSE:HR) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 18 items for HR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-03, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for HR spans S-3, 10-Q, 8-K, DEF 14A.

Recent high-impact activity:

  • Healthcare Realty Lifts 2026 Outlook on 5.1% Same-Store NOI Growth, Files New Shelf
  • Healthcare Realty Trust Registers 36M Shares for Resale Under $700M Exchangeable Notes
  • Healthcare Realty Narrows Loss, Raises FFO Guidance, and Signs $120M Nashville LOI
  • Healthcare Realty Trust Q2: Normalized FFO of $0.41, $42.8M in Impairments, and a $75M Buyback
  • Healthcare Realty Lifts 2026 Outlook, Unveils $200M in JV Acquisitions and $83M in Dispositions

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.18B
Net Income
-$246.07M
Diluted EPS
-$0.71
Op. Cash Flow
$457.1M
Free Cash Flow
$457M
Cash & Equivalents
$26.17M
Total Debt
$3.91B
Debt / Equity
0.85×
Net Margin
-20.8%
Shares Outstanding
351.6M sh
Source: 10-K · filed 2026-02-13 · accession 0001360604-26-000018

Short Interest & Short Volume

4.91 days to cover

FINRA reported short interest of 16,109,127 shares in HR as of the September 15, 2026 settlement, a 4.6% decrease from the prior period — about 4.9 days to cover at its recent average daily volume. On October 2, 2026, 41.7% of HR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)16,109,127 shares as of September 15, 2026
Change vs prior period▼ 4.6%
Days to cover4.91 at avg daily volume of 3,281,786
Daily short volume (FINRA facilities)41.7% of 1,312,970 shares on October 2, 2026
5-day average short volume52.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for HR, detected from its recent SEC filings · based on capital-structure filings through 2026-07-31.

1 recent capital raiseATM program2 shelf registrations

ATM Program Update · No New Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with H →
$17.47
52-week range · as of 2026-07-31 $15.29 – $22.04
Market cap
$5.99B
Volume
3.5M (0.9× avg)
3-mo avg 3.8M
Live data · 2026-10-05 04:23 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed HR - Latest Insights

HR
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $21.75
Real-time Price: $17.47 info
Change: -$4.28 (-20%) info
Market Cap: $5.987B info
HR
Jul 31, 2026, 5:26 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $21.01
Real-time Price: $17.47 info
Change: -$3.54 (-17%) info
Market Cap: $5.987B info
HR
Jul 31, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $21.18
Real-time Price: $17.47 info
Change: -$3.71 (-18%) info
Market Cap: $5.987B info
HR
Jul 30, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.18
Real-time Price: $17.47 info
Change: -$3.71 (-18%) info
Market Cap: $5.987B info
HR
Jul 30, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.18
Real-time Price: $17.47 info
Change: -$3.71 (-18%) info
Market Cap: $5.987B info
HR
Jul 30, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $21.49
Real-time Price: $17.47 info
Change: -$4.02 (-19%) info
Market Cap: $5.987B info
HR
May 19, 2026, 4:27 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $20.20
Real-time Price: $17.47 info
Change: -$2.73 (-14%) info
Market Cap: $5.987B info
HR
May 07, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $19.99
Real-time Price: $17.47 info
Change: -$2.52 (-13%) info
Market Cap: $5.987B info
HR
May 05, 2026, 6:55 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.94
Real-time Price: $17.47 info
Change: -$1.47 (-8%) info
Market Cap: $5.987B info
HR
May 05, 2026, 6:40 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.94
Real-time Price: $17.47 info
Change: -$1.47 (-8%) info
Market Cap: $5.987B info
HR
May 04, 2026, 7:23 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $17.47 info
Change: -$1.53 (-8%) info
Market Cap: $5.987B info
HR
May 01, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $19.25
Real-time Price: $17.47 info
Change: -$1.78 (-9%) info
Market Cap: $5.987B info
HR
Apr 30, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $18.70
Real-time Price: $17.47 info
Change: -$1.23 (-7%) info
Market Cap: $5.987B info
HR
Apr 07, 2026, 4:12 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $17.68
Real-time Price: $17.47 info
Change: -$0.210 (-1%) info
Market Cap: $5.987B info
HR
Feb 27, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.45
Real-time Price: $17.47 info
Change: -$0.980 (-5%) info
Market Cap: $5.987B info
HR
Feb 13, 2026, 4:16 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $17.96
Real-time Price: $17.47 info
Change: -$0.490 (-3%) info
Market Cap: $5.987B info
HR
Feb 12, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.49
Real-time Price: $17.47 info
Change: -$0.020 (-0.11%) info
Market Cap: $5.987B info
HR
Jan 07, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.05
Real-time Price: $17.47 info
Change: +$0.420 (+2%) info
Market Cap: $5.987B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets